Natazia



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 31.2%
Contraception 25.8%
Menorrhagia 15.1%
Menstrual Cycle Management 4.3%
Menstruation Irregular 3.2%
Endometriosis 2.2%
Genital Haemorrhage 2.2%
Menstrual Disorder 2.2%
Oral Contraception 2.2%
Bleeding Menstrual Heavy 1.1%
Blood Pressure Fluctuation 1.1%
Depression 1.1%
Dysfunctional Uterine Bleeding 1.1%
Dysmenorrhoea 1.1%
Fibroids 1.1%
Headache 1.1%
Hormone Level Abnormal 1.1%
Migraine 1.1%
Muscle Spasms 1.1%
Polycystic Ovaries 1.1%
Metrorrhagia 17.9%
Pregnancy On Oral Contraceptive 10.5%
No Adverse Event 8.4%
Vaginal Haemorrhage 8.4%
Menstruation Delayed 7.4%
Ovarian Cyst Ruptured 5.3%
Amenorrhoea 4.2%
Drug Dose Omission 4.2%
Abdominal Pain 3.2%
Chest Discomfort 3.2%
Headache 3.2%
Menstrual Disorder 3.2%
Off Label Use 3.2%
Rash 3.2%
Vomiting 3.2%
Withdrawal Bleed 3.2%
Biliary Colic 2.1%
Blood Pressure Increased 2.1%
Cerebrovascular Accident 2.1%
Extra Dose Administered 2.1%
Secondary
Menorrhagia 23.3%
Contraception 20.0%
Dysfunctional Uterine Bleeding 10.0%
Dysmenorrhoea 10.0%
Menstrual Cycle Management 6.7%
Bleeding Menstrual Heavy 3.3%
Genital Haemorrhage 3.3%
Headache 3.3%
Hormone Level Abnormal 3.3%
Menstrual Disorder 3.3%
Migraine 3.3%
Muscle Spasms 3.3%
Product Used For Unknown Indication 3.3%
Uterine Leiomyoma 3.3%
Pulmonary Embolism 28.6%
Menstruation Delayed 14.3%
Adverse Drug Reaction 7.1%
Menorrhagia 7.1%
Metrorrhagia 7.1%
Off Label Use 7.1%
Pregnancy On Oral Contraceptive 7.1%
Product Packaging Quantity Issue 7.1%
Thrombosis 7.1%
Uterine Leiomyoma 7.1%
Concomitant
Product Used For Unknown Indication 44.0%
Contraception 16.0%
Crohn's Disease 8.0%
Depression 8.0%
Pain 8.0%
Blood Triglycerides Increased 4.0%
Hypersensitivity 4.0%
Low Density Lipoprotein Increased 4.0%
Rheumatoid Arthritis 4.0%
Insomnia 33.3%
Cough 16.7%
Nausea 16.7%
Skin Burning Sensation 16.7%
Therapeutic Response Decreased 16.7%